Why the study?
Does aspirin prophylaxis prevent thromboembolic disease in patients undergoing total hip replacement?
Population
340 patients undergoing total hip replacement, excluding those with prior thromboembolic disease
Design
Cohort
Follow-up
postoperative
Authors
Loading...
Low event rates with aspirin post-hip replacement do not support practice change; leaves open efficacy in randomized trials.
Does aspirin prophylaxis prevent thromboembolic disease in patients undergoing total hip replacement?
Aspirin may be a simple and useful prophylactic agent for thromboembolic disease after total hip arthroplasty, though the lack of a control group limits definitive conclusions.
Jj et al. (1976) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: